Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Mineralys Therapeutics Inc., 3 years.
Mineralys Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2026 | Mineralys Therapeutics Inc. | Open-market sale | −104,320 | $28.81 | $3,005,303 |
| Feb 19, 2026 | Mineralys Therapeutics Inc. | Grant or award | +6,200 | — | — |
| Feb 19, 2026 | Mineralys Therapeutics Inc. | Other | −6,200 | — | — |
| Feb 19, 2026 | Mineralys Therapeutics Inc. | Other | +6,200 | — | — |
| Nov 20, 2025 | Mineralys Therapeutics Inc. | Open-market sale | −1,000,000 | $43.35 | $43,350,000 |
| Mar 13, 2025 | Mineralys Therapeutics Inc. | Open-market purchase | +259,259 | $13.50 | $3,499,997 |
| Jul 24, 2024 | Mineralys Therapeutics Inc. | Open-market sale | −550,000 | $13.05 | $7,177,500 |
| Feb 14, 2023 | Mineralys Therapeutics Inc. | Derivative conversion | +4,314,093 | — | — |
| Feb 14, 2023 | Mineralys Therapeutics Inc. | Open-market purchase | +250,000 | $16.00 | $4,000,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.